228 related articles for article (PubMed ID: 28836572)
1. Elevated Levels of Very Low-density Lipoprotein Cholesterol Independently Associated with In-stent Restenosis in Diabetic Patients after Drug-eluting Stent Implantation.
Qin Z; Zheng FW; Zeng C; Zhou K; Geng Y; Wang JL; Li YP; Ji QW; Zhou YJ
Chin Med J (Engl); 2017 Oct; 130(19):2326-2332. PubMed ID: 28836572
[TBL] [Abstract][Full Text] [Related]
2. New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent.
Wang JL; Qin Z; Wang ZJ; Shi DM; Liu YY; Zhao YX; Yang LX; Cheng WJ; Zhou YJ
J Geriatr Cardiol; 2018 Feb; 15(2):137-145. PubMed ID: 29662507
[TBL] [Abstract][Full Text] [Related]
3. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
[TBL] [Abstract][Full Text] [Related]
4. Remnant Lipoprotein Cholesterol Independently Associates With In-Stent Restenosis After Drug-Eluting Stenting for Coronary Artery Disease.
Xu X; Pandit RU; Han L; Li Y; Guo X
Angiology; 2019 Oct; 70(9):853-859. PubMed ID: 31167539
[TBL] [Abstract][Full Text] [Related]
5. Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis.
Zhao L; Zhu W; Zhang X; He D; Guo C
BMC Cardiovasc Disord; 2017 Jan; 17(1):16. PubMed ID: 28061808
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.
Zeng M; Yan X; Wu W
BMC Cardiovasc Disord; 2021 Sep; 21(1):446. PubMed ID: 34535088
[TBL] [Abstract][Full Text] [Related]
7. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
[TBL] [Abstract][Full Text] [Related]
9. Blood level of CD45+ platelets and development of restenosis after drug-eluting stent implantation in patients with stable coronary artery disease.
Gabbasov Z; Kozlov S; Byazrova S; Saburova O; Melnikov I; Caprnda M; Curilla E; Gaspar L; Kruzliak P; Smirnov V
Wien Klin Wochenschr; 2016 Dec; 128(23-24):898-905. PubMed ID: 27637207
[TBL] [Abstract][Full Text] [Related]
10. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ
Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
[TBL] [Abstract][Full Text] [Related]
11. Resistant in-stent restenosis in the drug eluting stent era.
Theodoropoulos K; Mennuni MG; Dangas GD; Meelu OA; Bansilal S; Baber U; Sartori S; Kovacic JC; Moreno PR; Sharma SK; Mehran R; Kini AS
Catheter Cardiovasc Interv; 2016 Nov; 88(5):777-785. PubMed ID: 27184223
[TBL] [Abstract][Full Text] [Related]
12. Predictor of in-stent restenosis in patients with drug-eluting stent (PRIDE)- a retrospective cohort study.
Gupta PK; Balachander J
Clin Investig Arterioscler; 2021; 33(4):184-194. PubMed ID: 33622608
[TBL] [Abstract][Full Text] [Related]
13. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
Almalla M; Pross V; Marx N; Hoffmann R
Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
[TBL] [Abstract][Full Text] [Related]
15. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
[TBL] [Abstract][Full Text] [Related]
16. Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry.
Lee JM; Rhee TM; Hahn JY; Hwang D; Park J; Park KW; Kim HL; Kim SH; Chae IH; Doh JH; Jeon KH; Choi YJ; Park JS; Choi SH; Gwon HC; Koo BK; Alfonso F; Kim HS
Int J Cardiol; 2017 Mar; 230():181-190. PubMed ID: 28043660
[TBL] [Abstract][Full Text] [Related]
17. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
Magalhaes MA; Minha S; Chen F; Torguson R; Omar AF; Loh JP; Escarcega RO; Lipinski MJ; Baker NC; Kitabata H; Ota H; Suddath WO; Satler LF; Pichard AD; Waksman R
Circ Cardiovasc Interv; 2014 Dec; 7(6):768-76. PubMed ID: 25466551
[TBL] [Abstract][Full Text] [Related]
18. Association of high level of hs-CRP with in-stent restenosis: A case-control study.
Baktashian M; Saffar Soflaei S; Kosari N; Salehi M; Khosravi A; Ahmadinejad M; Moohebati M; Ebrahimi M; Rahmani F; Khameneh-Bagheri R; Ahmadi M; Sadabadi F; Tayefi M; Bazhdanzadeh S; Ferns GA; Hashemi SM; Pasdar A; Ghayour-Mobarhan M
Cardiovasc Revasc Med; 2019 Jul; 20(7):583-587. PubMed ID: 30232022
[TBL] [Abstract][Full Text] [Related]
19. A prediction model based on platelet parameters, lipid levels, and angiographic characteristics to predict in-stent restenosis in coronary artery disease patients implanted with drug-eluting stents.
Gai MT; Zhu B; Chen XC; Liu F; Xie X; Gao XM; Ma X; Fu ZY; Ma YT; Chen BD
Lipids Health Dis; 2021 Sep; 20(1):118. PubMed ID: 34587955
[TBL] [Abstract][Full Text] [Related]
20. The relationship between fibrinogen-to-albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
Chen T; Sun JL; Zhang J
Coron Artery Dis; 2020 Nov; 31(7):586-589. PubMed ID: 32271235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
